CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
The association of spirometric small airways obstruction with respiratory symptoms, cardiometabolic diseases, and quality of life : results from the Burden of Obstructive Lung Disease (BOLD) study
Authors
Hazim Abozid
Rana Ahmed
+31 more
Mohammed Al Ghobain
Andre F.S. Amaral
Althea Aquart-Stewart
Cristina Barbara
A. Sonia Buist
Peter Burney
Hamid Hacene Cherkaski
Meriam Denguezli
Mohammed Elbiaze
Gregory E. Erhabor
Frits M.E. Franssen
Þórarinn Gíslason
Christer Janson
Ben Knox-Brown
Ali Kocabaş
Li Cher Loh
David Mannino
Guy Marks
Kevin Mortimer
Alexander Mueller
Asaad Ahmed Nafees
Daniel Obaseki
Stefanni Nonna M. Paraguas
Jaymini Patel
James Potts
Abdul Rashid
Sundeep Salvi
Terence Seemungal
Michael Studnicka
Wan C. Tan
Emiel F.M. Wouters
Publication date
1 January 2023
Publisher
Doi
Abstract
Funding Information: NHLI; Wellcome Trust grant (085790/Z/08/Z). Publisher Copyright: © 2023, The Author(s).Background: Spirometric small airways obstruction (SAO) is common in the general population. Whether spirometric SAO is associated with respiratory symptoms, cardiometabolic diseases, and quality of life (QoL) is unknown. Methods: Using data from the Burden of Obstructive Lung Disease study (N = 21,594), we defined spirometric SAO as the mean forced expiratory flow rate between 25 and 75% of the FVC (FEF25-75) less than the lower limit of normal (LLN) or the forced expiratory volume in 3 s to FVC ratio (FEV3/FVC) less than the LLN. We analysed data on respiratory symptoms, cardiometabolic diseases, and QoL collected using standardised questionnaires. We assessed the associations with spirometric SAO using multivariable regression models, and pooled site estimates using random effects meta-analysis. We conducted identical analyses for isolated spirometric SAO (i.e. with FEV1/FVC ≥ LLN). Results: Almost a fifth of the participants had spirometric SAO (19% for FEF25-75; 17% for FEV3/FVC). Using FEF25-75, spirometric SAO was associated with dyspnoea (OR = 2.16, 95% CI 1.77–2.70), chronic cough (OR = 2.56, 95% CI 2.08–3.15), chronic phlegm (OR = 2.29, 95% CI 1.77–4.05), wheeze (OR = 2.87, 95% CI 2.50–3.40) and cardiovascular disease (OR = 1.30, 95% CI 1.11–1.52), but not hypertension or diabetes. Spirometric SAO was associated with worse physical and mental QoL. These associations were similar for FEV3/FVC. Isolated spirometric SAO (10% for FEF25-75; 6% for FEV3/FVC), was also associated with respiratory symptoms and cardiovascular disease. Conclusion: Spirometric SAO is associated with respiratory symptoms, cardiovascular disease, and QoL. Consideration should be given to the measurement of FEF25-75 and FEV3/FVC, in addition to traditional spirometry parameters.Peer reviewe
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Maastricht University Research Portal
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:cris.maastrichtuniversity....
Last time updated on 06/08/2023
Publikationer från Uppsala Universitet
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:DiVA.org:uu-512806
Last time updated on 30/09/2023
Maastricht University Research Portal
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:cris.maastrichtuniversity....
Last time updated on 05/08/2023
Digitala Vetenskapliga Arkivet - Academic Archive On-line
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:DiVA.org:uu-512806
Last time updated on 29/09/2023